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The effects of adrenergic agonists and glucagon on respiration and cytosolic free Caz+, measured with quin2, 
in female rat hepatocytes have been compared. In the presence of lactate, all three agonists caused a perma- 
nent stimulation of respiration. However, unlike phenylephrine, glucagon induced only a transient increase 
in cytosolic free Ca2+, and isoprenaline caused no detectable change. Mechanisms other than Ca2+ for respi- 
ratory stimulation by CAMP-linked agonists in liver are indicated. 
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1. INTRODI JCTION 
Adrenaline, glucagon and other glycogenolytic 
hormones stimulate respiration in perfused liver 
[I,21 and i@ated hepatocytes [3,4], but the 
regulatory mechanisms have not been resolved. 
These hormqnes increase the proportion of 
pyruvate dehydrogenase in the active, non- 
phosphorylated form [5,6] and, indirect evidence 
suggests, activate cu-oxoglutarate dehydrogenase 
[7,9]. However, there is no evidence for 
stimulatory lincreases in CoA/acetyl-CoA, 
ADP/ATP or /NAD/NADH and indeed the latter 
ratio decreases [S, 10,111. These enzymes together 
with NAD-lin$ted isocitrate dehydrogenase are 
markedly activ ted by Ca” in a number of mam- 
malian 18 tiss ,es including liver [12,13]. 
Noradrenaline,: glucagon and the a-adrenergic 
agonist phenylephrine all raise cytosolic free Ca2+ 
in liver cells [ 14,151 and, in the absence of any hor- 
monally imposed constraint on mitochondrial 
Ca2+ transpo t, 
L 
would be predicted to raise 
mitochondrial a’+ as well. Evidence for a role of 
intr~itochon~rial Ca2+ in the activation of these 
enzymes in liver in response to adrenaline and 
glucagon has been reported recently [ 161. 
The question of whether glucagon and 
Ca2+-mobilizing hormones both affect mitochon- 
drial oxidative metabolism via Ca2+ is fundamen- 
tal since, if this is the case, the role of Ca2+ as an 
intracellular messenger in liver would be extended 
to the action of CAMP-linked agonists. This study 
examines this issue and concludes that whereas 
respiration correlates with cytosolic free Ca2+ with 
phenylephrine as agonist, no such correlation is 
evident with either glucagon or the P-adrenergic 
agonist, isoprenaline. 
2. MATERIALS AND METHODS 
2.1. Preparation of dispersed liver ceils loaded 
with quin2 
Hepatocytes were prepared from 200-300 g fed, 
female Sprague Dawley rats by the collagenase 
method as in [17] and suspended finally in Krebs- 
Henseleit medium containing (mM) NaCl (124), 
KC1 (5.0), MgS04 (1.2), KHzP04 (1,2), CaCl2 
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(1.3), NaHC03 (26) and 2% (w/v) bovine serum free Ca2+ using an apparent dissociation constant 
albumin. Cell DNA was determined as in [23]. of 110 nM [15]. 
The cells were loaded with quin2 by incubation 
(approx. 3 mg cell dry wt/ml) with the esterified 
indicator (acetoxymethyl tetra ester, 100/M in 
dimethyl sulphoxide) as described in [ 141. After 
15 min the cells were centrifuged at approx. 50 x 
g for 1 min, washed twice by resuspension in 
Krebs-Henseleit medium (above) and sedimenta- 
tion. The cells were stored on ice. 
3. RESULTS AND DISCUSSION 
2.2. Hepatocyte incubations 
All incubations were carried out at 37°C in 
Krebs-Henseleit medium (above) containing 
10 mM lactate unless otherwise stated. A prein- 
cubation period of 15 min was observed in all 
cases. Respiration was measured with Clarke-type 
02 electrodes. In each experiment wo separate in- 
cubations with 02 electrodes (polarized by a com- 
mon circuit) were performed in parallel, agonist 
was added to one of these, and the outputs 
displayed on a dual pen recorder (respiration vs 
time). The voltage difference between the two 
high-potential inputs was measured on a second 
recorder to give change in respiration at any time 
caused by the agonist (A respiration vs time). 
In assessing the involvement of Ca2+ in the 
regulation of hepatic oxidative metabolism by cy- 
adrenergic and CAMP-linked agonists it was ad- 
vantageous to use cells that display both a- 
adrenergic and ,&adrenergic responses. Studer and 
Borle [19,20] concluded from studies of glycogen 
phosphorylase activation that female rats utilize 
both types of adrenergic receptor, unlike adult 
male rats in which cu-adrenergic mechanisms 
predominate. Initial experiments therefore in- 
vestigated the relative capacity of the a-adrenergic 
agonist phenylephrine and the P-adrenergic agonist 
isoprenaline to stimulate respiration in female rat 
hepatocytes. 
Changes in quin2 fluorescence were measured in 
parallel with respiration with a Perkin-Elmer 3000 
spectrometer operating at 342 nm excitation and 
492 nm emission. The suspension was stirred con- 
tinuously. The maximal fluorescence signal (Ca2+ 
saturation of quin2) was obtained by dissolving the 
cells with 1% Triton X-100. The signal at 2 nM 
Ca2+ was obtained by further addition of 20 mM 
EGTA. The fluorescence signal was converted to 
In the presence of lactate (table l), all three 
agonists tested stimulated respiration; the stimula- 
tion with isoprenaline was about 75% of that with 
phenylephrine. Similar effects of all three agonists 
were observed when lactate was replaced with 
pyruvate (not shown). The phenylephrine- and 
glucagon-induced responses were unaffected by 
the absence of substrate. However, omission of 
substrate abolished significant stimulation of 
respiration by isoprenaline. Unlike with the other 
agonists, therefore, ,&adrenergic stimulation of 
respiration depends critically on the presence of 
substrate. It is conceivable that with isoprenaline 
as agonist, rate limitation by pyruvate 
dehydrogenase must be overcome by increased 
[pyruvate] in order for respiratory stimulation to 
Table 1 
The effects of adrenergic agonists and glucagon on respiration in 
hepatocytes in the presence and absence of lactate 
female rat 
Substrate Control value Stimulation (Yo) of respiration by 
of respirationa 
Phenylephrine Isoprenaline Glucagon 
None 2.1 f 0.1 28 + 3 (3)b 5 f 5 (6) 32 i 5 (4)’ 
Lactate 2.5 z!z 0.2 32 f 4 (3)b 24 f 3 (5)d 34 f 4 (4)c 
Respiration was measured 5 min after agonist. The following [agonist] were added: 
1OpM phenylephrine, 1 /IM isoprenaline, 10 nM glucagon. Cells not loaded with 
quin2 were used. Units: ’ ngatom O/min per pg DNA. Significance, P: b ~0.02; 
' <O.Ol; d ~0.002. Data are given as means + SE (no. of independent experiments) 
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be expressed, and that isoprenaline may stimulate 
oxidation of pyruvate at a step subsequent o 
pyruvate dehydrogen~e. 
Fig.1 reports changes in quin2 fluorescence, 
calibrated for [Ca’+], and respiration in the 
presence of lactate. Following the 15 min prein- 
cubation period, cytosolic free Ca2’ in the absence 
of agonist was about 70 nM (fig.la), which is 
rather lower than that reported previously in 
resting cells (100-200 nM [15]). In this and all 
other preparations reported, resting cytosolic free 
Ca2+ was maintained constant for at least 10 min 
after the preincubation period. Previous 
measurements of phenylephrine- and glucagon- 
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Fig. 1. The effects of adrenergic agonists and glucagon 
on cytosolic Ca” and respiration in quin2 loaded 
hepatocytes. (a) Quin2 fluorescence traces calibrated for 
free [Ca2’]. All the baselines before agonist addition 
were superimposable. The initial stage of phenylephrine- 
induced change (indicated by the dashed line) was not 
recorded since it occurred within the mixing time (5 s). 
(b) 02 consumption vs time. (c) A02 consumption (test 
minus control) vs time. The following agonists were 
introduced at the arrows: phenylephrine (P, 10&M), 
isoprenaline (I, 1 ,zM), glueagon (G, 10 nM). Control, 
Calibration of the maximal fluorescence change 
(2 nM-1.3 mM Ca’+) with quin2 indicated a 
cellular quint content of 0.7-1.5 nmol/mg dry wt. 
With the assumption of 2.4~1 intracellular 
HzO/mg dry wt of cells 1141, this amount of quin2 
corresponds to an internal [quin2] of 
0.29-0.62 m&I. Since this would introduce signifi- 
cant additional Ca2+ buffering to the cytosol, ex- 
periments examined whether the agonist-induced 
activation of respiration was changed by quin2 
loading. Fig.2 compares agonist-induced activa- 
tion of respiration in quin2-loaded and non-loaded 
cells of the same preparations. The responses were 
not affected significantly by quin2 loading. Unlike 
phenylephrine, glucagon-induced stimulation in- 
volved a pronounced lag phase of almost 30 s. 
no agonist, Fig.3 collates data from a number of 
induced changes in cytosolic Ca2’ were terminated 
at 30 s 1141; the effect of isoprenaline has not been 
reported. In the present study, phenylephrine in- 
duced a rapid rise in cytosolic free Ca2’ that was 
partially maintained with time. Glucagon caused a 
smaller, more slowly developing increase in 
cytosolic free Ca2’ that was transient. In contrast, 
isoprenaline did not change cytosolic free Ca2+ 
detectably. Other experiments revealed similar ef- 
fects of these agonists in the absence of added lac- 
tate. In sham experiments (not shown) with 
hepatocytes subjected to the same loading pro- 
cedure with the solvent dimethyl sulphoxide, but 
without quin2 ester, none of the above agonists 
caused any detectable fluorescence change at the 
wavelengths used to measure the quin2 response. 
Thus the fluorescence changes (or absence of) with 
quinZloaded cells may be correlated with changes 
in quin2 fluorescence. 
Respiration was measured in parallel with the 
fluorescence measurements. In practice it was dif- 
ficult to discern small changes in respiration with 
time in response to agonist from conventional 
traces (fig.lb), and therefore the difference in 02 
content between control and test incubations (test 
minus control) was determined as in fig. lc (section 
2). In fig.lc a downward deflection of the trace 
corresponds to stimulation by agonist and the 
negative slope of the trace at any instant is propor- 
tional to the degree of respiratory stimulation at 
that instant. It is evident that all three agonists 
stimulated respiration irrespective of their quite 
different effects on cytosolic free Ca2’. 
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Fig.2. The effect of quin2 loading on the stimulation of 
respiration by phenylephrine and glucagon. The 
respiratory stimulations with phenylephrine (P, 10 PM) 
and glucagon (G, 10 nM) were calculated from traces of 
the type in fig. lc using hepatocytes from the same stock 
with quin2 loading (closed symbols) and without quin2 
loading (open symbols). Data are given as means of 
either 3 (P) or 4 (G) determinations with separate 
hepatocyte preparations. Bars indicate SE. 
quin2-loaded hepatocyte preparations. 
Phenylephrine induced an overall 4-Sfold in- 
crease in cytosolic free Ca2+ initially which 
decreased with time, but was then maintained at 
about 3-fold the resting level. The respiratory 
stimulation was quite constant at 30%. With 
glucagon as agonist the transient increase in 
cytosolic Ca2+ was not reflected in respiration; in- 
deed in the period 3-5 min after glucagon ad- 
ministration, when cytosolic Ca2+ was restored to 
the resting level, there was a further small rise in 
respiration which was then maintained at the same 
rate as with phenylephrine. Moreover, the perma- 
nent stimulation of respiration by isoprenaline was 
not accompanied by any detectable increase in 
cytosolic Ca’+. 
Mitochondrial Ca2+ in liver is established by a 
transport cycle in which Ca2+ influx via the 
uniporter is balanced by Ca2+ efflux via the 
Na+-Ca2+ carrier [21] and, possibly, an 
Na+-independent Ca2+ transport system. Denton 
and McCormack [12,16] have proposed that 
hormone-induced increases in cytosolic free Ca2+ 
Fig.3. The increases in respiration and cytosolic free 
Ca2+ by adrenergic agonists and glucagon in 
quinZloaded hepatocytes. Respiration and Ca2+ were 
determined in parallel in the same quin2-loaded cells. 
Results are given as means of determinations with the 
following number of cell preparations: P (10 pM 
phenylephrine), 5; G (10 nM glucagon), 5; I (1 pM 
isoprenaline), 3. Bars indicate SE. 
may be relayed by the cycle to the mitochondrial 
matrix with consequent activation of oxidative 
metabolism. The present data fully support this 
concept as applied to phenylephrine action on 
liver. The present study indicates, however, that 
the stimulation of respiration by isoprenaline can- 
not be attributed to relay of increased cytosolic 
free Ca2+ to the mitochondrial matrix, at least 
under the incubation conditions employed. The 
same conclusion applies to the later time course of 
glucagon action. Increased mitochondrial Ca2+ in 
the absence of increased cytosolic Ca2+ would re- 
quire either uniporter activation or inhibition of 
the mitochondrial Ca2+ efflux systems. We have 
shown previously that administration of glucagon 
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or isoprenaline (but not phenylephrine) to perfused 
female rat livers stimulates Na+-Ca’+ carrier ac- 
tivity 2-3-fold, at least in subsequently isolated 
mitochondria, and is without effect on the 
uniporter or the Na+-independent system [22-241. 
A decrease in hepatocyte mitochondrial 45Ca2+ 
after glucagon addition has also been reported 
[25]. Taken together, these observations suggest 
that respiratory stimulation by CAMP-linked 
agonists can occur in liver without Ca2+ as 
mediator. 
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